|
|
Article: PREVACID(R) NapraPAC(TM) Now Available In Dallas; Convenient New Option For Patients Taking NSAIDS for the Treatment of Arthritis Who Are at Risk for Recurrent Stomach Ulcers.
- Article from:
- PR Newswire
- Article date:
- March 1, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LAKE FOREST, Ill., March 1 /PRNewswire/ -- TAP Pharmaceutical Products Inc. announced today that PREVACID(R) NapraPAC(TM) (lansoprazole delayed-release capsules and naproxen tablets kit) is now available in Dallas, TX and throughout the United States. PREVACID NapraPAC was recently approved by the U.S. Food and Drug Administration (FDA) for reducing the risk of nonsteroidal anti-inflammatory drug (NSAID) -- associated gastric ulcer in people with a history of documented gastric ulcer that require the use of an NSAID for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. Controlled studies did not extend beyond 12 ...